Medical Xpress
NOVEMBER 18, 2022
A comprehensive genomic analysis in more than 200 patients with metastatic urothelial carcinomas may help inform how a patient would respond to immunotherapy, report UNC Lineberger Comprehensive Cancer Center researchers and colleagues. About 90% of urothelial carcinomas are bladder cancers.
Drug Discovery Today
AUGUST 5, 2021
(Oslo, August 5, 2021) Molecular diagnostics specialist, Genetic Analysis AS (GA) today announced the first publication from the comprehensive HumGut microbiome database has appeared in the leading scientific journal Microbiome.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
SEPTEMBER 10, 2020
Computational method capable of decoding influence of rare variants Geneticists could identify the causes of disorders that currently go undiagnosed if standard practices for collecting individual genetic information were expanded to capture more variants that researchers can now decipher, concludes new Johns Hopkins University research.
Scienmag
APRIL 26, 2022
In the most comprehensive genetic analysis of the native people there to date, researchers reveal that the ethnic groups’ peopling and migration history is more complex than previously concluded. China’s mountainous southwestern area is home to one of the country’s most ethnically diverse populations.
The Pharma Data
JANUARY 7, 2021
Now, research is helping to bring genetic risks for people of various racial and ethnic groups into focus. Researchers from the USC Center for Genetic Epidemiology in Los Angeles and the Institute of Cancer Research in London led the study. 4 in the journal Nature Genetics. THURSDAY, Jan.
Delveinsight
FEBRUARY 25, 2021
Cambridge, Massachusetts-based Beam aims to make more precise edits with genetic medicines, which employ base-editing. Instead of snipping the genome, base editing lets for edits of individual letters in a genetic sequence. Beam employs three approaches to deliver its genetic medicines to cells.
pharmaphorum
APRIL 5, 2022
Researchers at the Institute of Cancer Research (ICR) in London have designed a prototype test that they think could be used to predict which combinations are likely to work in cancer patients within two days. The researchers are already planning a larger follow-up study which will test 15 drugs and look at 12,000 tumour cell proteins.
Expert insights. Personalized for you.
98 
Let's personalize your content